Late Breaking Abstract - Exciting phase 1 data on RESP-X, a novel monoclonal antibody targeting a key virulence mechanism of Pseudomonas aeruginosa, with potential as a treatment to reduce exacerbations in non-CF bronchiectasisEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Evaluation of Homogentisic Acid, a Prospective Antibacterial Agent Highlighted by the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) Clinical TrialCELLSIF5.22023-06-211OAAI
Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant EnterobacteralesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62020-11-0511OAAI
Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant BacteriaANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52017-05-0143OAAI
Efficacy of a Novel Tricyclic Topoisomerase Inhibitor in a Murine Model of Neisseria gonorrhoeae InfectionANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52016-09-018OAAI
In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerasesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62016-06-268OAAI
Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IVJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62016-03-3027OA
Discovery of the first inhibitors of bacterial enzyme D-aspartate ligase from Enterococcus faecium (ASlfm)EUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92013-09-0128PREAI
Staphylococcus aureus Biofilms Promote Horizontal Transfer of Antibiotic ResistanceANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52013-04-01271OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向